GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinocelltech Group Ltd (SHSE:688520) » Definitions » EV-to-Revenue

Sinocelltech Group (SHSE:688520) EV-to-Revenue : 11.26 (As of May. 11, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Sinocelltech Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sinocelltech Group's enterprise value is ¥24,456 Mil. Sinocelltech Group's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,171 Mil. Therefore, Sinocelltech Group's EV-to-Revenue for today is 11.26.

The historical rank and industry rank for Sinocelltech Group's EV-to-Revenue or its related term are showing as below:

SHSE:688520' s EV-to-Revenue Range Over the Past 10 Years
Min: 8.81   Med: 71.65   Max: 36819.46
Current: 11.52

During the past 8 years, the highest EV-to-Revenue of Sinocelltech Group was 36819.46. The lowest was 8.81. And the median was 71.65.

SHSE:688520's EV-to-Revenue is ranked worse than
57.71% of 1038 companies
in the Biotechnology industry
Industry Median: 8.305 vs SHSE:688520: 11.52

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-11), Sinocelltech Group's stock price is ¥49.44. Sinocelltech Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4.92. Therefore, Sinocelltech Group's PS Ratio for today is 10.06.


Sinocelltech Group EV-to-Revenue Historical Data

The historical data trend for Sinocelltech Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocelltech Group EV-to-Revenue Chart

Sinocelltech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - 59,382.90 194.72 27.04 14.01

Sinocelltech Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.77 18.51 15.00 14.01 9.53

Competitive Comparison of Sinocelltech Group's EV-to-Revenue

For the Biotechnology subindustry, Sinocelltech Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinocelltech Group's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinocelltech Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sinocelltech Group's EV-to-Revenue falls into.



Sinocelltech Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sinocelltech Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=24456.437/2171.073
=11.26

Sinocelltech Group's current Enterprise Value is ¥24,456 Mil.
Sinocelltech Group's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,171 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinocelltech Group  (SHSE:688520) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sinocelltech Group's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=49.44/4.916
=10.06

Sinocelltech Group's share price for today is ¥49.44.
Sinocelltech Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4.92.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinocelltech Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sinocelltech Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinocelltech Group (SHSE:688520) Business Description

Traded in Other Exchanges
N/A
Address
Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, Courtyard 31, Beijing, CHN, 100176
Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.

Sinocelltech Group (SHSE:688520) Headlines

No Headlines